Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Not Confirmed
Not Confirmed
03-06 November, 2024
2024 ACI Convention2024 ACI Convention
Not Confirmed
Not Confirmed
03-07 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Industry Trade Show
Not Confirmed
03-06 November, 2024
2024 ACI Convention2024 ACI Convention
Industry Trade Show
Not Confirmed
03-07 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/due-to-its-20-year-mastery-in-micronization-inke-has-emerged-a-cornerstone-in-treating-global-respiratory-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/dmf-filings-hit-all-time-high-in-q3-2024-china-tops-list-with-58-increase-in-type-ii-submissions
Details:
Nemera's multidose eye dropper Novelia® has been approved by ANVISA for the preservative-free formulations CLILON (Ketorolac 0,4% and 0,5%), a nonsteroidal anti-inflammatory drug that is used to treat moderately severe pain and inflammation, usually after surgery.
Lead Product(s): Ketorolac Trometamol
Therapeutic Area: Ophthalmology Brand Name: Clilon
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Ache Laboratorios Farmaceuticos SA
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable May 06, 2021
Lead Product(s) : Ketorolac Trometamol
Therapeutic Area : Ophthalmology
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Ache Laboratorios Farmaceuticos SA
Deal Size : Not Applicable
Deal Type : Not Applicable
Nemera’s Preservative-Free Multi-Dose Eyedropper Approved in Brazil for Aché’s NSAID’s and ...
Details : Nemera's multidose eye dropper Novelia® has been approved by ANVISA for the preservative-free formulations CLILON (Ketorolac 0,4% and 0,5%), a nonsteroidal anti-inflammatory drug that is used to treat moderately severe pain and inflammation, usually aft...
Brand Name : Clilon
Molecule Type : Small molecule
Upfront Cash : Not Applicable
May 06, 2021
Services
Packaging
ABOUT THIS PAGE
Nemera is a supplier offers 3 products (APIs, Excipients or Intermediates).
Find a price of SINGLE SIDED SILICONISED OPP 60 MICRONS bulk offered by Nemera
Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL AND GENERAL OPERATING PROCEDURES IN EVANSVILLE AND PRINCETON, INDIANA bulk offered by Nemera
Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN HAMPSHIRE, UNITED KINGDOM. bulk offered by Nemera
LOOKING FOR A SUPPLIER?